Mather Group’s Contineum Therapeutics CTNM Stock Holding History

Mather Group’s Portfolio CTNM Stock Details CTNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.83K	Buy	+211	New	+$3.14K	﹤0.01%	1965

Other funds holding CTNM

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mather Group's CTNM Position: Q3 2026 in Review

Mather Group opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 211 shares worth $2.83K. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings.

4 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

Mather Group held 211 shares of Contineum Therapeutics worth $2.83K as of Q3 2026.
Contineum Therapeutics was a new Mather Group position in Q3 2026.
Contineum Therapeutics made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1965 holding.
4 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.